News from diamyd medical ab A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 15, 2019, 06:00 ET Diamyd Medical Enters Agreement for Intralymphatic Diamyd ® Trial in LADA

The agreement with the Norwegian University of Science and Technology in Trondheim (NTNU) refers to a first, investigator initiated clinical Phase II ...


Sep 09, 2019, 09:14 ET Feasibility Study Supports the use of Intralymphatic Injections of Diamyd®

A feasibility study performed as a Master Thesis at Uppsala University and supervised by Diamyd Medical, supports the use of ultrasound guided...


Jun 04, 2019, 02:36 ET New Interim Report at 30 Months and After Extra Injection Supports Long-term Effect of Intralymphatic Diamyd®

The first seven patients that have now been followed for the entire 30-month period in DIAGNODE-1 continue to show a positive clinical course and are ...


May 29, 2019, 09:07 ET The Swedish Medical Products Agency Approves New Treatment Arm With Remygen® and Alprazolam in Phase I/II Trial ReGenerate-1

The approval by the Swedish MPA entails that ReGenerate-1, with Diamyd Medical's GABA-based investigational drug Remygen®, will be expanded from the...


Mar 26, 2019, 03:45 ET Diamyd Medical Announces Strategic Activities for 2019 and 2020

With experience from clinical trials in more than 1,000 patients with the diabetes vaccine Diamyd®, preparations for a Conditional Marketing...


Dec 06, 2018, 02:31 ET Diamyd Medical Raises SEK 58.4 Million in Funds Through Redemption of Warrants

During 1 to 30 November 2018, holders of warrants of series TO 1 B and TO 2 A of Diamyd Medical AB have been able to subscribe for shares through...


Oct 23, 2018, 02:52 ET New Immunological Results That Support Intralymphatic Treatment With Diamyd® to be Presented at the Immunology of Diabetes Society Congress

New results of intralymphatic treatment with the diabetes vaccine Diamyd® indicate the induction of a long-term immune response that supports the...